GT Biopharma Inc (GTBP)
3.325
+0.10
(+2.99%)
USD |
NASDAQ |
May 10, 16:00
3.30
-0.02
(-0.75%)
After-Hours: 20:00
GT Biopharma Free Cash Flow: -8.852M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.852M |
| September 30, 2023 | -11.10M |
| June 30, 2023 | -12.06M |
| March 31, 2023 | -12.91M |
| December 31, 2022 | -15.22M |
| September 30, 2022 | -14.62M |
| June 30, 2022 | -15.64M |
| March 31, 2022 | -17.14M |
| December 31, 2021 | -15.61M |
| September 30, 2021 | -13.83M |
| June 30, 2021 | -11.60M |
| March 31, 2021 | -10.72M |
| December 31, 2020 | -7.262M |
| September 30, 2020 | -5.82M |
| June 30, 2020 | -5.245M |
| March 31, 2020 | -2.921M |
| December 31, 2019 | -3.659M |
| September 30, 2019 | -4.418M |
| June 30, 2019 | -6.725M |
| March 31, 2019 | -7.412M |
| December 31, 2018 | -10.71M |
| September 30, 2018 | -11.59M |
| June 30, 2018 | -10.39M |
| March 31, 2018 | -9.008M |
| December 31, 2017 | -5.43M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.413M |
| June 30, 2017 | -1.739M |
| March 31, 2017 | -2.413M |
| December 31, 2016 | -1.93M |
| September 30, 2016 | -2.739M |
| June 30, 2016 | -2.809M |
| March 31, 2016 | -3.037M |
| December 31, 2015 | -4.657M |
| September 30, 2015 | -4.751M |
| June 30, 2015 | -4.696M |
| March 31, 2015 | -3.446M |
| December 31, 2014 | -1.749M |
| September 30, 2014 | -1.08M |
| June 30, 2014 | -0.457M |
| March 31, 2014 | -0.394M |
| December 31, 2013 | -0.442M |
| September 30, 2013 | -0.287M |
| June 30, 2013 | -0.61M |
| March 31, 2013 | -0.933M |
| December 31, 2012 | -0.987M |
| September 30, 2012 | -1.097M |
| June 30, 2012 | -0.918M |
| March 31, 2012 | -1.008M |
| December 31, 2011 | -0.963M |
| September 30, 2011 | -1.016M |
Free Cash Flow Range, Past 5 Years
-17.14M
Minimum
Mar 2022
-2.921M
Maximum
Mar 2020
-10.28M
Average
-11.10M
Median
Sep 2023
Free Cash Flow Benchmarks
| Cutera Inc | -170.88M |
| Outlook Therapeutics Inc | -47.10M |
| 180 Life Sciences Corp | -10.92M |
| Journey Medical Corp | 0.24M |
| NovaBay Pharmaceuticals Inc | -4.15M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.047M |
| Cash from Investing (Quarterly) | 0.478M |
| Free Cash Flow Per Share (Quarterly) | -1.426 |
| Free Cash Flow Yield | -195.6% |